Secretome Therapeutics

Secretome Therapeutics

This biotechnology company develops therapies derived from neonatal cardiac progenitor cells for patients with heart failure and Duchenne muscular dystrophy.

Phlox Therapeutics

This company develops RNA-based gene therapies to treat patients with rare genetic heart diseases, including cardiomyopathies and laminopathies.

Heartseed

Heartseed develops cell-based regenerative therapies and transplantation devices for patients with severe heart failure and other cardiac diseases.

Alder Therapeutics

This company develops allogeneic stem cell therapies to treat patients with retinitis pigmentosa and chronic heart failure.

Serca Pharmaceuticals

This company develops cardioprotective drugs to treat patients suffering from myocardial infarction and heart failure by modulating the SERCA2 calcium pump.

MyoPax

This company develops muscle regeneration cell and gene therapies for patients with congenital malformations, trauma, hereditary dystrophies and muscle wasting disorders.

Theratome Bio

This company develops stem-cell secretome therapeutics to treat ischemic brain injury, dry eye disease and organ transplant preservation for healthcare providers and patients.

Nuevocor

Nuevocor develops gene therapies for patients with genetic cardiomyopathies by addressing mechanical defects through its proprietary mechanobiology platform.